NasdaqCM - Delayed Quote USD

BioNexus Gene Lab Corp. (BGLC)

3.7000
-0.5900
(-13.75%)
At close: June 2 at 4:00:02 PM EDT
3.9499
+0.25
+(6.75%)
After hours: June 2 at 7:55:44 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Su-Leng Tan CEO, President, Acting CFO, Secretary & Director 491.13k -- 1984
Mr. Kwan Wah Chan Marketing Manager -- -- --
Mr. Too Kam Tham Managing Director -- -- --

BioNexus Gene Lab Corp.

Menara UOA Bangsar
Unit A-28-7, Level 28, Tower A No.5 Jln Bangsar Utama 1
Kuala Lumpur, 59000
Malaysia
60 1 307 241 6898 https://www.bionexusgenelab.com
Full Time Employees: 
30

Description

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Corporate Governance

BioNexus Gene Lab Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 15, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 29, 2025 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

April 15, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

April 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 3, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 31, 2025 at 12:00 AM UTC

NT 10-K: Periodic Financial Reports

March 25, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 7, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 5, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers